Tekla Cash from 2010 to 2024

HQH Stock  USD 17.43  0.03  0.17%   
Tekla Healthcare's Cash is decreasing with very volatile movements from year to year. Cash is predicted to flatten to 182.97. Cash is the total amount of money in the form of currency that Tekla Healthcare Investors has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1996-03-31
Previous Quarter
14.1 K
Current Value
14.1 K
Quarterly Volatility
12.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tekla Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tekla Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Interest Expense of 0.0 or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 113, Dividend Yield of 0.0246 or PTB Ratio of 0.58. Tekla financial statements analysis is a perfect complement when working with Tekla Healthcare Valuation or Volatility modules.
  
Check out the analysis of Tekla Healthcare Correlation against competitors.

Latest Tekla Healthcare's Cash Growth Pattern

Below is the plot of the Cash of Tekla Healthcare Investors over the last few years. Cash refers to the most liquid asset of Tekla Healthcare Inv, which is listed under current asset account on Tekla Healthcare Investors balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Tekla Healthcare customers. The amounts must be unrestricted with restricted cash listed in a different Tekla Healthcare account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Tekla Healthcare's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tekla Healthcare's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Very volatile
   Cash   
       Timeline  

Tekla Cash Regression Statistics

Arithmetic Mean410,921
Coefficient Of Variation451.00
Mean Deviation971,724
Median935.00
Standard Deviation1,853,274
Sample Variance3.4T
Range8.9M
R-Value(0.11)
Mean Square Error3.7T
R-Squared0.01
Significance0.70
Slope(44,523)
Total Sum of Squares48.1T

Tekla Cash History

2024 182.97
2023 192.6
2022 214.0
2021 792.0
2020 935.0
2019-2.5 M
20181.7 M

Other Fundumenentals of Tekla Healthcare Inv

Tekla Healthcare Cash component correlations

About Tekla Healthcare Financial Statements

Investors use fundamental indicators, such as Tekla Healthcare's Cash, to determine how well the company is positioned to perform in the future. Although Tekla Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cash 192.60  182.97 
Cash And Short Term Investments 246.10  233.80 
Change In Cash(664.70)(631.46)
Free Cash Flow-127 M-120.6 M
Begin Period Cash Flow 910.80  865.26 
Other Cashflows From Financing Activities198.1 M208 M
Other Non Cash Items-50.7 M-53.2 M
Total Cash From Operating Activities-127 M-120.6 M
Total Cash From Financing Activities162.2 M170.3 M
End Period Cash Flow 246.10  233.80 
Total Cashflows From Investing Activities27.3 M25 M
Free Cash Flow Yield(0.16)(0.15)
Operating Cash Flow Per Share(4.53)(4.30)
Free Cash Flow Per Share(4.53)(4.30)
EV To Operating Cash Flow(8.29)(7.88)
EV To Free Cash Flow(8.29)(7.88)
Price To Operating Cash Flows Ratio(8.29)(7.88)
Price To Free Cash Flows Ratio(8.29)(7.88)
Cash Conversion Cycle 218.77  360.88 
Operating Cash Flow Sales Ratio(75.67)(71.88)
Price Cash Flow Ratio(8.29)(7.88)

Currently Active Assets on Macroaxis

When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:
Check out the analysis of Tekla Healthcare Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.145
Dividend Share
1.66
Earnings Share
1.31
Revenue Per Share
0.197
Quarterly Revenue Growth
(0.06)
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.